±¬ÁÏTV

Appraisal-specific

E Poku, J Rathbone, R Wong, E Everson-Hock, M Essat, A Pandor, A Wailoo. . 2014 BMJ Open 4:e005244. DOI: 10.1136/bmjopen-2014-005244

A Wailoo, N Bansback, J Chilcott. Rheumatology 2008; Vol 47 (10): 1590.

A Wailoo, N Bansback, J Chilcott. Rheumatology 2008; Vol 47 (2): 119-120.

A Wailoo, A Sutton, A Morgan. 2009 British Journal of Cancer Vol 100: 436-441.

S Lloyd, S Bujkiewicz, A Wailoo, A Sutton, D Scott. . Rheumatology 2010; Vol 49 (12): 2313-2321.

Methods development

Wailoo A, Bell Gorrod H, Dunning L, Kenny J, Leckenby E, Shah K. The NICE experience of designing and utilising severity weights. Health Policy OPEN, Volume 10, 2026, 100156, ISSN 2590-2296. DOI:

M Hernández Alava, SE Pudney, AJ Wailoo (2023). Does EQ-5D tell the whole story? Statistical methods for comparing the thematiccoverage of clinical and generic outcome measures, with application to breast cancer. Value in Health. DOI: 

A. Scope, A. Bhadhuri and B. Pennington (2022) "". Value in Health. DOI: https://doi.org/10.1016/j.jval.2022.02.008

Rowen D, Mukuria C, Powell P A, Wailoo A. "". PharmacoEconomics, Accepted: 24 January 2022, Online 16/03/2022.

Laura A Gray, Monica Hernandez Alava and Allan J Wailoo (2021) Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer. BMC Cancer 21:1237 DOI:

A review of the psychometric performance of selected child and adolescent preference-based measures used to generate utility values for children. Value in Health 2020; ISSN 1098-3015; DOI:

J Hill, D Rowen, R Pennington, A Wailoo, R Wong (2020) A review of the methods used to generate utility values in NICE technology assessments for children and adolescents. Value in Health, 2020, 23(7): 907-917. DOI:

(August 2018). To install the command within Stata use "ssc install eq5dmap".

(August 2018).

(October 2017).

S E Grimm, M Strong, A Brennan et al. (January 2016) Framework for analysing risk in health technology assessments and its application to managed entry agreements (PDF, 1.5MB).

S E Grimm, M Strong, A Brennan et al. (2017) . PharmacoEconomics 35: 1287.

M Hernández Alava, A Wailoo. ALDVMM: A command for fitting adjusted limited dependent variable mixture models to EQ-5D. The Stata Journal 2015 In press. Available online.

B Pennington, S Davis (December 2014) . Value in Health 17(8):762-771.

K K Shah, A Tsuchiya, A Wailoo (2015) . Social Science and Medicine; 124:48-56 (first published online November 2014).

M Hernández Alava, A Wailoo, F Wolfe, K Michaud (2014) . Medical Decision Making; 34: 919-930 (first published online 2013 DOI: 10.1177/0272989X13500720).

O Ciani, S Davis, P Tappenden, R Garside, K Stein, A Cantrell, E D Saad, M Buse, R S Taylor (2014) . International Journal of Technology Assessment in Health Care; 30(3): 312-324.

K K Shah, A Tsuchiya, A Wailoo (2014) . European Journal of Health Economics; 15(4): 389-399 (first published online May 2013; DOI: 10.1007/s10198-013-0482-3).

B Kearns, R Ara, A Wailoo, A Manca, M Hernandez Alava, K Abrams, M Campbell (2013) . PharmacoEconomics; 31(8): 643-652.

P Thokala, A Duenas (2012) . Value in Health; 15(8): 1172-1181.

S Davis, A Wailoo (2013) . Health and Quality of Life Outcomes; 11(20).

K K Shah, A Tsuchiya, A Wailoo. Valuing health at the end of life: An exploratory preference elicitation study (PDF, 364KB). HEDS Discussion Paper 11/17.

J Morden, P Lambert, N Latimer, K Abrams, A Wailoo (2011) BMC Medical Research Methodology; Vol 11:4.

A Wailoo, A Tsuchiya, C McCabe (2009) . PharmacoEconomics; 27(12): 983-989.

A Wailoo, A Sutton, N Cooper, D Turner, K Abrams, A Brennan, K Nicholson (2008) . Value in Health; 11(2): 160-171.

Technical support documents

Population adjustment

D Phillipo, A Ades, S Dias, S Palmer, K Abrams, N Welton (February 2018) . Med Decis Making; 38(2): 200-211. DOI: 10.1177/0272989X17725740

Evidence synthesis

S Dias, N Welton, A Sutton, A Ades (July 2013) . Med Decis Making; 33: 597-606. DOI: 10.1177/0272989X13487604

S Dias, A Sutton, A Ades, N Welton (July 2013) . Med Decis Making; 33: 607-617, first published on October 26, 2012. DOI: 10.1177/0272989X12458724

S Dias, A Sutton, N Welton, A Ades (July 2013) . Med Decis Making; 33: 618-640, DOI: 10.1177/0272989X13485157

S Dias, N Welton, A Sutton, D Caldwell, G Lu, A Ades (July 2013) . Med Decis Making; 33: 641-656. DOI: 10.1177/0272989X12455847

S Dias, N Welton, A Sutton, A Ades (July 2013) . Med Decis Making; 33: 657-670. DOI: 10.1177/0272989X13485155

S Dias, A Sutton, N Welton, A Ades (July 2013) . Med Decis Making; 33: 671-678. DOI: 10.1177/0272989X13487257

A Ades, D Caldwell, S Reken, N Welton, A Sutton, S Dias (July 2013) . Med Decis Making; 33: 679-691. DOI: 10.1177/0272989X13485156

Utilities

Papaioannou, J Brazier, S Paisley (2013) . Value in Health; 16(4): 686-695.

L Longworth, D Rowen (2013) . Value in Health; 16(1): 202-210.

R Ara, A Wailoo (2012) . Value in Health; 15: 6.

Survival analysis

N Latimer (2013) . Medical Decision Making; 33(6): 743-754.

A Bagust, S Beale (2013). . Medical Decision Making. DOI: 10.1177/0272989X13497998

N Latimer (2013). . Medical Decision Making. DOI: 10.1177/0272989X13511302

Methods Guide update process 2008

A Miners (2008) . PharmacoEconomics, 26(9): 745-751.

A Sutton, A E Ades, N Cooper, K Abrams, (2008) . PharmacoEconomics, 26(9): 753-767.

M Sculpher (2008) . PharmacoEconomics, 26(9): 799-806.

C McCabe, K Claxton, A J Culyer (2008) . PharmacoEconomics, 26(9): 733-744.

K Claxton (2008) . PharmacoEconomics, 26: 781-798.

J Brazier (2008) . PharmacoEconomics, 26(9): 769-779.